Pyrophosphoric Acid

Pyrophosphoric Acid

SCHEMBL374861

CC(C)(c1ccccc1)c1ccc(OC(c2ccc(C(C)(C)c3ccccc3)cc2C(C)(C)c2ccccc2)C(CO)(CO)CO)c(C(C)(C)c2ccccc2)c1.O=P(O)(O)OP(=O)(O)O

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.33
ALDH1A1 P00352 6/20 0.33
MEN1 O00255 5/20 0.33
KMT2A Q03164 5/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
LMNA P02545 2/20 0.33
POLB P06746 2/20 0.33
TDP1 Q9NUW8 1/20 0.31
HTT P42858 2/20 0.31
GAA P10253 1/20 0.30
ESR1 P03372 1/20 0.30
CYP3A4 P08684 1/20 0.30
ESR2 Q92731 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL77938 0.92 KDM4E (0.36) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL374860 0.91 BTN3A1 (0.32) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL6837322 0.88 KDM4E (0.34) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL5598652 0.88 KDM4E (0.34) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL190544 0.88 KDM4E (0.34) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL4302020 0.86 CYP2C19 (0.34) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL28643112 0.86 KDM4E (0.33) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL4305432 0.84 KDM4E (0.35) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL16876756 0.83 CYP1A2 (0.32) KDM4EMEN1KMT2ALMNAPOLB
SCHEMBL29027349 0.82 KDM4E (0.32) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 184 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260028489-A1 SUPPORTED POLYMERIZATION INHIBITORS AND THEIR USE IN CURABLE COMPOSITIONS FOR 3D PRINTING ALIGN TECHNOLOGY INC (US) 2026-01-29 US claimed
US-12351704-B2 Use of recycled polyethylene in closures for bottles NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) 2025-07-08 US claimed
EP-4045589-B1 USE OF RECYCLED POLYETHYLENE IN CLOSURES FOR BOTTLES NOVA CHEM INT SA (CH) 2024-11-27 EP claimed
US-20240093007-A1 USE OF RECYCLED POLYETHYLENE IN CLOSURES FOR BOTTLES NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) 2024-03-21 US claimed
US-20240084150-A1 THERMALLY STABILISED CONDUCTIVE POLYMER COATINGS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2024-03-14 US claimed
CN-116948378-A Flat glass fiber reinforced single-walled carbon nanotube modified PC composite material and preparation method thereof 深圳市富恒新材料股份有限公司 2023-10-27 CN claimed
EP-4263729-A1 THERMALLY STABILISED CONDUCTIVE POLYMER COATINGS Commonwealth Scientific and Industrial Research Organisation (AU) 2023-10-25 EP claimed
CN-116848200-A Thermally stable conductive polymer coating 联邦科学和工业研究组织 2023-10-03 CN claimed
US-11708489-B2 Thermoplastic polycarbonate resin composition and molded product formed therefrom LOTTE CHEMICAL CORPORATION (KR) 2023-07-25 US claimed
US-20230108463-A1 PHOSPHORUS-CONTAINING COMPOUNDS AS ADDITIVES FOR SILICON-BASED LI ION BATTERIES ENEVATE CORPORATION 2023-04-06 US claimed
CN-106633312-B Oil-resistant high-temperature-resistant halogen-free flame-retardant thermal shrinkage identification tube and production method thereof 深圳市沃尔核材股份有限公司 2020-11-27 CN claimed
EP-3720706-A1 HIGH PERFORMANCE POLYAMIDE COMPOUNDS AND USES THEREOF LyondellBasell Advanced Polymers Inc. (US) 2020-10-14 EP claimed
CN-108431115-B Abusive molded articles comprising UV stabilized polycarbonate 沙特基础工业全球技术公司 2020-08-28 CN claimed
CN-111433026-A High-performance polyamide compound and use thereof 利安德巴塞尔先进聚合物公司 2020-07-17 CN claimed
WO-2019112910-A1 HIGH PERFORMANCE POLYAMIDE COMPOUNDS AND USES THEREOF A. SCHULMAN, INC. (US) 2019-06-13 WO claimed
US-20190169433-A1 HIGH PERFORMANCE POLYAMIDE COMPOUNDS AND USES THEREOF A. SCHULMAN, INC. (US) 2019-06-06 US claimed
EP-3374426-A1 ABUSIVELY MOLDED ARTICLE INCLUDING UV-STABLE POLYCARBONATE SABIC Global Technologies B.V. (NL) 2018-09-19 EP claimed
WO-2017103764-A1 ABUSIVELY MOLDED ARTICLE INCLUDING UV-STABLE POLYCARBONATE SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2017-06-22 WO claimed
US-9095189-B2 Aging-resistant copolymers comprising polyamide blocks and polyether blocks ARKEMA FRANCE (FR) 2015-08-04 US claimed
WO-2007136565-A1 STABILIZER COMPOSITIONS CYTEC TECHNOLOGY CORP. (US) 2007-11-29 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230108463-A1 PHOSPHORUS-CONTAINING COMPOUNDS AS ADDITIVES FOR SILICON-BASED LI ION BATTERIES PHOSPHO1, PSPH, SELENOI KDM4E 3693/4885ALDH1A1 2669/4885MEN1 2224/4885
US-20260028489-A1 SUPPORTED POLYMERIZATION INHIBITORS AND THEIR USE IN CURABLE COMPOSITIONS FOR 3D PRINTING ILK, MTCL3, MARK3 KDM4E 152/4885ALDH1A1 2419/4885MEN1 3491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.